Over the next five years the Procalcitonin (CAS 56645-65-9) market will register a 7.6% CAGR in terms of revenue, the global market size will reach US$ 93 million by 2027.
Procalcitonin (CAS 56645-65-9) Market Overview
Procalcitonin or PCT has a molecular weight of around 13kDa and it is a 116 amino acid residue protein. PCT is peptide hormone which is primarily produced by the thyroid C cells and specific endocrine cells of the lung. Usually Procalcitonin is immediately cleaved into 3 particular fragments; calcitonin, an N terminal residue and Katacalcin.
With 13% market share globally, Thermo Fisher was the biggest manufacturer in the Procalcitonin market which was followed by bioMerieux, Wuhan easy diagnosis biomedicine, Beijing Apis, Roche diagnostics, BBI solutions, Prospec, HyTest, Nanjing norman biological technology, Snibe, Getein Biotech, Lumigenex, Ningbo and more. The top manufacturers in the market possess a market share of 35%. Europe, in the year 2018 remained the largest in terms of production as well as consumption.
Who are the Major Players in Procalcitonin (CAS 56645-65-9) Market?
Top Key players in the Procalcitonin (CAS 56645-65-9) Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Procalcitonin (CAS 56645-65-9) Market is fragmented with a large number of small players operating worldwide. The companies referred in the market research report includes Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis and others.
Industry News-
- In August 2021 - Thermo Fisher Scientific Collaborates with ChromSword to Deliver Rapid Automated HPLC and UHPLC Method Development System : Thermo Fisher Scientific, the world leader in serving science, and ChromSword, a provider of innovative software products, have collaborated to launch an automated high performance liquid chromatography (HPLC) and ultra-high performance liquid chromatography (UHPLC) method development system that enables chromatographers to deliver robust and validated methods in less time and with higher confidence.
- In July 2021 - Thermo Fisher Scientific Announces Collaboration with Ortho Clinical Diagnostics : Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS analyzers.
- In September 2021 - Mindray Completes Acquisition of HyTest : Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (“Mindray”) (300760.SZ), a leading global provider of medical devices and solutions, has completed its previously announced acquisition of HyTest Invest Oy and its subsidiaries (“HyTest”), a global leading provider of antibodies and antigens.
What are the major Applications, Types and Regions for Procalcitonin (CAS 56645-65-9) Market?
By Type, Procalcitonin (CAS 56645-65-9) Market has been segmented into
- Procalcitonin Antigen
- Procalcitonin Antibody
By Application, Procalcitonin (CAS 56645-65-9) Market has been segmented into
- Medical Industry
- Scientific Research
- Veterinarian
Regional Analysis On Procalcitonin (CAS 56645-65-9) Market -
North America, one of the top performers in the Procalcitonin (CAS 56645-65-9) market, will show significant growth throughout the forecast period because to marketing research tools and solid foundations. Nonetheless, companies and administrations, as well as external managers, are generating client-driven items that will help the district grow. The Procalcitonin (CAS 56645-65-9) market will grow due to rising interest, increased pay, trend-setting innovation, and apparatus, as well as attention-demanding initiatives. With such a large population, Asia-Pacific will be interested in the figure year and will be able to dominate the Procalcitonin (CAS 56645-65-9) market share in a short period of time. Recent GDP increases, as well as per capita and infrastructure advancements, have urbanised the region into metropolitan areas.
The report offers in-depth assessment of the growth and other aspects of the Procalcitonin (CAS 56645-65-9) Market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
Procalcitonin (CAS 56645-65-9) Market highlights the potential growth opportunities in upcoming years, while reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape and other key aspects in the global market. The Global Procalcitonin (CAS 56645-65-9) Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Procalcitonin (CAS 56645-65-9) Market report scope?
Report Attributes
|
Report Details
|
Forecast Period 2022 to 2027 CAGR
|
CAGR of 7.6% over the forecast period (2022-2027)
|
By Type
|
- Procalcitonin Antigen
- Procalcitonin Antibody
|
By Application
|
- Medical Industry
- Scientific Research
- Veterinarian
|
By Companies
|
Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
Base Year
|
2022
|
Historical Year
|
2017 to 2021
|
Forecast Year
|
2022 to 2027
|
Number of Pages
|
122
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Key Takeaways from this Procalcitonin (CAS 56645-65-9) Report
- Evaluate Procalcitonin (CAS 56645-65-9) market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
- Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.
- Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
- Analyze the sales and distribution channels across key geographies to improve top-line revenues.
- Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
- Get a quick outlook on the Procalcitonin (CAS 56645-65-9) market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
- Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
Frequently Asked Questions
How do you conduct primary research interviews?
We use tools such as video conferences, telephone calls, face-to-face interviews, and questionnaires with key respondents.
What if the report I want is not listed in the repository of your reports?
Market Insights Reports has a repository of reports on various industry verticals and not all of them have been listed on the website. Please contact our sales team with your requirements.
Who are the key players in Procalcitonin (CAS 56645-65-9) Market?
Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis
What regions does this Procalcitonin (CAS 56645-65-9) Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Procalcitonin (CAS 56645-65-9) Market?
Procalcitonin Antigen, Procalcitonin Antibody
What are the major end-use applications of the Procalcitonin (CAS 56645-65-9) Market?
Medical Industry, Scientific Research, Veterinarian
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
